Marsh & McLennan (MMC) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Marsh & McLennan (MMC)

168.15

+1.00 (0.60%)

as of Jun 11, 2026, 8:00:00 pm Market Open.

27 watching

PAST TOP PICK

(A Top Pick Feb 06/24, Up 13%)

Benefiting from continued tight market conditions in insurance market, which (perversely) is bolstered by climate change. Consultancy side is a play on the labour market, which remains robust.

TOP PICK

Their reinsurance business increases when premiums increase. Also operate consulting businesses. Recently bought it. Expects double-digit returns over the cycle.

(Analysts’ price target is $201.35)

PARTIAL BUY

It consistently earns, a good company. Buy some now and buy some more cheaper.

DON'T BUY

Insurance brokerage business is profitable, but technology will depress margins. Well run, but has benefited from PE expansion. Hard to see the upside. Great company, but rather fully priced.

PAST TOP PICK

(A Top Pick Apr 22/19, Down 7%) If you can get this at $64 he would be very happy.

PAST TOP PICK

(A Top Pick Apr 22/19, Up 21%) It could pull back to 101.60 but he would be a buyer in another $10 dollars.

TOP PICK

Model price of $115.23 which is an 8% upside. This is a solid company. (Analysts’ price target is $106.06)

TOP PICK

$112.32 is his target. Low volatility. Has long owned this and done well with it. Days of rigging bids and price fixing are long behind them. (Analysts’ price target is $93.94)

SELL

(Market Call Minute.) Management is terrible. Margins are under pressure. Would buy Willis Group (WSH-N) instead.

BUY

Probably a pretty reasonable buy right now after their sale of the Putnam Group. By most measures, it is a little undervalued.

BUY

Has gone through a lot of problems in the last 6 months or so. Senior management has been let go and there is talk about people rigging their bidding for certain aspects. The component parts of their company are actually pretty good. New management has cleared up a lot of the issues and thinks there's a lot more upside in this company.

DON'T BUY

Has a hard time understanding exactly what's in it or what the new model will look like. Was extremely profitable. It threw off cash. Had a high ROE. There were things going on that increased the profitability. Would stand back on this one.

DON'T BUY

Model price is $34.64. Prefers other cheaper companies.

WAIT

Have seen earnings estimates fall because of the lack of business that they were going to be getting. Using last Sept's balance sheet, feel that it is worth around $33.45. Want to see the write offs before buying.

DON'T BUY

Is in difficulty. Don't know what the underlying business is going to transform to. Also has a credibility issue.

Showing 1 to 15 of 23 entries

Marsh & McLennan (MMC) Frequently Asked Questions

What is Marsh & McLennan stock symbol?

Marsh & McLennan is a American stock, trading under the symbol MMC (previously MMC-N on Stockchase) on the New York Stock Exchange (MMC). It is usually referred to as NYSE:MMC or MMC

Is Marsh & McLennan a buy or a sell?

In the last year, there was no coverage of Marsh & McLennan published on Stockchase.

Is Marsh & McLennan a good investment or a top pick?

Marsh & McLennan was recommended as a Top Pick by Danny Tomka on 2004-11-09. Read the latest stock experts ratings for Marsh & McLennan.

Why is Marsh & McLennan stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Marsh & McLennan worth watching?

0 stock analysts on Stockchase covered Marsh & McLennan in the last year. It is a trending stock that is worth watching.

What is Marsh & McLennan stock price?

On 2026-06-11, Marsh & McLennan (MMC) stock closed at a price of $168.15.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Kim Bolton

Black Swan Dexteritas

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Marsh & McLennan (MMC)